Regenerx Biopharmaceuticals (RGRX) Net Income by Year
Regenerx Biopharmaceuticals reported a net loss of $1.7M in fiscal year 2022. This represents a decrease of 8.1% from the prior fiscal year. Over the trailing 12 months, Q2 FY2022 through Q1 FY2023, the same line adds up to a $1.7M net loss. The table below carries 13 fiscal years, from 2010 to 2022, and the quarters Regenerx Biopharmaceuticals has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
RGRX Net Income by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
TTM is the trailing twelve months, Q2 FY2022 through Q1 FY2023, summed from the four most recent quarterly filings.
RGRX Net Income by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
What net income means
Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line.
More Regenerx Biopharmaceuticals financials
Frequently Asked Questions
What was Regenerx Biopharmaceuticals's net income in fiscal year 2022?
Regenerx Biopharmaceuticals reported a net loss of $1.7M in fiscal year 2022.
How fast is Regenerx Biopharmaceuticals's net income growing?
Regenerx Biopharmaceuticals (RGRX) net income fell by 8.1% year over year, from -$1.6M to -$1.7M in fiscal year 2022.
What is Regenerx Biopharmaceuticals's net income over the last twelve months?
Regenerx Biopharmaceuticals (RGRX) reported a $1.7M net loss over the trailing 12 months, Q2 FY2022 through Q1 FY2023, summed from the four most recent quarterly filings.
How has Regenerx Biopharmaceuticals's net income changed over the years?
Across the 13 fiscal years this page covers, Regenerx Biopharmaceuticals (RGRX) net income went from -$5.0M in fiscal year 2010 to -$1.7M in fiscal year 2022.
What was Regenerx Biopharmaceuticals's net income in the most recent quarter?
Regenerx Biopharmaceuticals (RGRX) reported -$385K in net income in Q1 2023. This represents an increase of 9.2% from the same quarter a year earlier.
What does net income mean on a financial statement?
Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line. This page lists what Regenerx Biopharmaceuticals (RGRX) reported on that line in every period on record.